Perceptive Advisors »

Ascendis Pharma AS shares owned by Perceptive Advisors

Quarter-by-quarter ownership of Ascendis Pharma AS (ASND) shares owned by Perceptive Advisors from 13F filings

Historical chart of Perceptive Advisors investment in Ascendis Pharma AS

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma AS held by Perceptive Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma AS by Perceptive Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $310M 1.2M 266.72

More positions owned by Perceptive Advisors

Praxis Precision Medicines I Com New (PRAX)
Spyre Therapeutics Com New (SYRE)
Celcuity (CELC)
Ascendis Pharma A/s Ord Shs (ASND)
Rhythm Pharmaceuticals (RYTM)
Roivant Sciences SHS (ROIV)
Relay Therapeutics (RLAY)
Travere Therapeutics (TVTX)
Kardigan Ord
Nuvalent Inc-a (NUVL)
Edgewise Therapeutics (EWTX)
Apogee Therapeutics (APGE)
Amylyx Pharmaceuticals (AMLX)
Meiragtx Holdings (MGTX)
Oruka Therapeutics (ORKA)

View all positions for Perceptive Advisors

Top funds holding Ascendis Pharma AS

RA Capital Management
Westfield Capital Management Company
Jupiter Topco
Artisan Partners Limited Partnership
T. Rowe Price Associates
American Century Companies
Perceptive Advisors
Principal Financial Group
Goldman Sachs Group
Citadel Advisors
Alliancebernstein
Jpmorgan Chase & Co
Bank of New York Mellon
Jane Street
Pictet Asset Management Holding SA

View all funds holding Ascendis Pharma AS